PapersPMID:41208045
Association of preoperative metformin use with postoperative mortality and morbidity in type 2 diabetes patients undergoing noncardiac surgery: a retrospective cohort study.
What moved
1 findingHow to read these marks →- Decreases all-cause mortality
moderate
“Before weighting, the 30-day and five-year mortalities after surgery were lower in the metformin group than in the non-metformin group (0.3% vs. 1.0%; P < 0.001 for 30-day mortality and 13.6% vs. 19.7%; P < 0.001 for five-year mortality).”
- Study
- cohort
- Population
- adults with type 2 diabetes undergoing noncardiac surgery, metformin users vs non-users; secondary endpoint, unadjusted (before IPTW weighting), five-year follow-up horizon
Study record
- Design
- cohort study
- Species
- human
- Population
- Adult patients with type 2 diabetes mellitus using antidiabetic agents at hospital admission, undergoing noncardiac surgery 2011-2019 at Samsung Medical Center, Seoul, Korea
- Participants
- 22,944
- Comparator
- observational
- Duration
- 2,995 days
- Endpoints measured
- 12
metformin